. 2017 Oct-Dec;8(4):155–165. doi: 10.4103/jpp.JPP_34_17
Copyright: © 2018 Journal of Pharmacology and Pharmacotherapeutics
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Table 3.
Adverse effects of lercanidipine compared with placebo
